HMGB1 and plasma cell myeloma: The alkaloid lycorine restores sensitivity to the proteasome inhibitor bortezomib in multiple myeloma by promoting the proteasomal degradation of HMGB1, which in turn inhibits pro-survival autophagy by disrupting the MEK/ERK signaling axis [237].